• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonyl compounds Benzenesulfonyl halides

Recent Advances in the Application of 4-Chloro-2-cyanobenzene-1-sulfonyl chloride (CAS: 1251087-10-1) in Chemical and Pharmaceutical Research

4-Chloro-2-cyanobenzene-1-sulfonyl chloride (CAS: 1251087-10-1) is a key intermediate in the synthesis of various biologically active compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its versatility as a building block for sulfonamide derivatives, which are known for their broad spectrum of pharmacological activities. This research brief aims to summarize the latest findings related to this compound, focusing on its synthetic applications, biological relevance, and potential therapeutic implications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 4-chloro-2-cyanobenzene-1-sulfonyl chloride as a precursor for novel sulfonamide-based kinase inhibitors. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against several cancer-related kinases, with IC50 values in the nanomolar range. Molecular docking simulations further revealed that the sulfonyl chloride moiety plays a critical role in binding to the ATP pocket of target kinases, suggesting its potential as a scaffold for anticancer drug development.

Another significant application of this compound was reported in a recent ACS Chemical Biology article, where it was utilized in the synthesis of covalent inhibitors for SARS-CoV-2 main protease (Mpro). The researchers designed a series of sulfonyl chloride derivatives that could form irreversible bonds with the catalytic cysteine residue of Mpro, effectively inhibiting viral replication. Among these derivatives, one compound showed remarkable antiviral activity in cell-based assays, highlighting the potential of 4-chloro-2-cyanobenzene-1-sulfonyl chloride in antiviral drug discovery.

Beyond its pharmaceutical applications, this compound has also found use in chemical biology as a versatile labeling reagent. A 2024 study in Chemical Communications described its application in the site-specific modification of proteins through sulfonylation reactions. The researchers successfully labeled lysine residues in various proteins, enabling the study of protein-protein interactions and post-translational modifications. This approach offers a valuable tool for proteomics research and the development of targeted therapies.

From a synthetic chemistry perspective, recent advances have focused on improving the efficiency and selectivity of reactions involving 4-chloro-2-cyanobenzene-1-sulfonyl chloride. A 2023 Organic Letters publication reported a novel catalytic system for the selective sulfonylation of aromatic compounds using this reagent, achieving high yields under mild conditions. This methodology could significantly streamline the production of sulfonamide-based drugs and reduce the environmental impact of pharmaceutical manufacturing.

In conclusion, 4-chloro-2-cyanobenzene-1-sulfonyl chloride (CAS: 1251087-10-1) continues to demonstrate its importance as a multifunctional intermediate in chemical and pharmaceutical research. Recent studies have expanded its applications from traditional drug discovery to cutting-edge chemical biology techniques. As research progresses, we anticipate further innovations in the utilization of this compound, particularly in the development of targeted therapies for challenging diseases such as cancer and viral infections.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)